These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7907680)

  • 41. Assessment of association of D3 dopamine receptor MscI polymorphism with schizophrenia: analysis of symptom ratings, family history, age at onset, and movement disorders.
    Gaitonde EJ; Morris A; Sivagnanasundaram S; McKenna PJ; Hunt DM; Mollon JD
    Am J Med Genet; 1996 Sep; 67(5):455-8. PubMed ID: 8886161
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association between schizophrenia and homozygosity at the dopamine D3 receptor gene.
    Crocq MA; Mant R; Asherson P; Williams J; Hode Y; Mayerova A; Collier D; Lannfelt L; Sokoloff P; Schwartz JC
    J Med Genet; 1992 Dec; 29(12):858-60. PubMed ID: 1362221
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of aripiprazole and the Taq1A polymorphism in the dopamine D2 receptor gene on the clinical response and plasma monoamine metabolites level during the acute phase of schizophrenia.
    Miura I; Takeuchi S; Katsumi A; Mori A; Kanno K; Yang Q; Mashiko H; Numata Y; Niwa S
    J Clin Psychopharmacol; 2012 Feb; 32(1):106-9. PubMed ID: 22198450
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association of DRD2 gene variant with schizophrenia.
    Kukreti R; Tripathi S; Bhatnagar P; Gupta S; Chauhan C; Kubendran S; Janardhan Reddy YC; Jain S; Brahmachari SK
    Neurosci Lett; 2006 Jan; 392(1-2):68-71. PubMed ID: 16183199
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A search for association between schizophrenia and dopamine-related alleles.
    Jönsson E; Brené S; Geijer T; Terenius L; Tylec A; Persson ML; Sedvall G
    Eur Arch Psychiatry Clin Neurosci; 1996; 246(6):297-304. PubMed ID: 8908411
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Association of schizophrenia with a promoter polymorphism in the dopamine D2 receptor gene].
    Peng DH; Wang GH; Cheng ZL; Zhang DX; Jiang KD
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Feb; 22(1):94-5. PubMed ID: 15696493
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [D3 dopamine receptor gene Ser9Gly polymorphism in Russian patients with schizophrenia].
    Aksenova MG; Shestakova IuN; Abramova LI; Frolova LP; Shemiakina TK; Lezheĭko TV; Lavrushina OM; Barkhatova AN; Nosikov VV; Golimbet VE
    Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(10):57-61. PubMed ID: 15553379
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An association study of dopaminergic (DRD2) and serotoninergic (5-HT2) gene polymorphism and schizophrenia in a North Indian population.
    Kaur G; Singh Chavan B; Gupta D; Sinhmar V; Prasad R; Tripathi A; Garg PD; Gupta R; Khurana H; Gautam S; Margoob MA; Aneja J
    Asian J Psychiatr; 2019 Jan; 39():178-184. PubMed ID: 30389402
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Further evidence supporting the association between the dopamine receptor D2 Ser/Cys311 variant and disorganized symptomatology of schizophrenia.
    Serretti A; Lilli R; Lorenzi C; Smeraldi E
    Schizophr Res; 2000 Jun; 43(2-3):161-2. PubMed ID: 11001590
    [No Abstract]   [Full Text] [Related]  

  • 50. Polymorphisms of dopamine D2-like (D2, D3, and D4) receptors in schizophrenia.
    Ohara K; Nakamura Y; Xie DW; Ishigaki T; Deng ZL; Tani K; Zhang HY; Kondo N; Liu JC; Miyasato K; Ohara K
    Biol Psychiatry; 1996 Dec; 40(12):1209-17. PubMed ID: 8959285
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The dopamine D2 receptor 5'-flanking variant, -141C Ins/Del, is not associated with reduced dopamine D2 receptor density in vivo.
    Pohjalainen T; Någren K; Syvälahti EK; Hietala J
    Pharmacogenetics; 1999 Aug; 9(4):505-9. PubMed ID: 10780270
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The C/C genotype of the C957T polymorphism of the dopamine D2 receptor is associated with schizophrenia.
    Lawford BR; Young RM; Swagell CD; Barnes M; Burton SC; Ward WK; Heslop KR; Shadforth S; van Daal A; Morris CP
    Schizophr Res; 2005 Feb; 73(1):31-7. PubMed ID: 15567074
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evidence for an association between the dopamine D3 receptor gene DRD3 and schizophrenia.
    Ebstein RP; Macciardi F; Heresco-Levi U; Serretti A; Blaine D; Verga M; Nebamov L; Gur E; Belmaker RH; Avnon M; Lerer B
    Hum Hered; 1997; 47(1):6-16. PubMed ID: 9017973
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association between schizophrenia and DRD3 or HTR2 receptor gene variants.
    Baritaki S; Rizos E; Zafiropoulos A; Soufla G; Katsafouros K; Gourvas V; Spandidos DA
    Eur J Hum Genet; 2004 Jul; 12(7):535-41. PubMed ID: 15083167
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A genetic polymorphism in the promoter region of DRD4 associated with expression and schizophrenia.
    Okuyama Y; Ishiguro H; Toru M; Arinami T
    Biochem Biophys Res Commun; 1999 May; 258(2):292-5. PubMed ID: 10329380
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gender-specific molecular heterosis of dopamine D2 receptor gene (DRD2) for smoking in schizophrenia.
    Lee HS; Kim SH; Lee HJ; Kim L; Lee SK; Jang DW; Lee MS; Son BG; Suh KY; Kim S
    Am J Med Genet; 2002 Aug; 114(6):593-7. PubMed ID: 12210271
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Association of allele polymorphism of dopamine d2 receptors with schizophrenic and affective disorders].
    Golimbet VE; Aksenova MG; Abramova LI; Kaleda VG; Orlova VA; Braga EA; Nosikov VV; Trubnikov VI
    Zh Nevrol Psikhiatr Im S S Korsakova; 1998; 98(12):32-5. PubMed ID: 9866157
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Repeat length variation in the dopamine D4 receptor gene shows no evidence of association with schizophrenia.
    Daniels J; Williams J; Mant R; Asherson P; McGuffin P; Owen MJ
    Am J Med Genet; 1994 Sep; 54(3):256-8. PubMed ID: 7810584
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Study of association between the ser-9-gly polymorphism of the D3 dopaminergic receptor and schizophrenia].
    Cordeiro Q; Junqueira R; Vallada H
    Arq Neuropsiquiatr; 2001 Jun; 59(2-A):219-22. PubMed ID: 11400029
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Correlation between the effectiveness of atypical antipsychotics and dopamine D3 receptor polymorphism in schizophrenia].
    Szekeres G; Juhász A; Kéri S; Rimanóczy A; Szendi I; Szabó Z; Janka Z
    Ideggyogy Sz; 2002 Nov; 55(11-12):377-81. PubMed ID: 12632798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.